Home / Recalls / Nostrum Laboratories Inc / D-0473-2018

D-0473-2018 Class III Terminated

Recalled by Nostrum Laboratories Inc — Kansas City, MO

Recall Details

Product Type
Drugs
Report Date
February 28, 2018
Initiation Date
February 13, 2018
Termination Date
December 13, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,439,000 oral capsules

Product Description

Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02

Reason for Recall

Presence of Foreign Tablets/Capsules

Distribution Pattern

Nationwide

Code Information

Lot: CAL173502; Exp. 09/19

Other recalls by Nostrum Laboratories Inc

  • D-0547-2025 Class II — Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003- (July 11, 2025)
  • D-0249-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per b (January 25, 2021)
  • D-0227-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 tablets per b (January 4, 2021)
  • D-0068-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, (October 23, 2020)
  • D-0067-2021 Class II — Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, (October 23, 2020)
  • D-1059-2020 Class II — Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx (March 6, 2020)
  • D-1030-2016 Class II — Nitrofurantoin Oral Suspension, USP, 25 mg/5 mL, FOR ORAL USE ONLY, URINARY TRAC (May 23, 2016)